Chinook Therapeutics, Inc.

DB:290A Stock Report

Market Cap: €2.6b

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Chinook Therapeutics Past Earnings Performance

Past criteria checks 0/6

Chinook Therapeutics's earnings have been declining at an average annual rate of -41.1%, while the Biotechs industry saw earnings growing at 11% annually. Revenues have been growing at an average rate of 49% per year.

Key information

-41.1%

Earnings growth rate

60.8%

EPS growth rate

Biotechs Industry Growth-14.6%
Revenue growth rate49.0%
Return on equity-68.8%
Net Margin-4,199.9%
Last Earnings Update30 Jun 2023

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Chinook Therapeutics makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

DB:290A Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 236-246440
31 Mar 235-216400
31 Dec 226-188360
30 Sep 2257-118340
30 Jun 2254-92310
31 Mar 2254-97300
31 Dec 2152-103320
30 Sep 211-160350
30 Jun 211-149310
31 Mar 211-114270
31 Dec 201-82190
30 Sep 200-5280
30 Jun 200-5461
31 Mar 200-4822
31 Dec 190-4726

Quality Earnings: 290A is currently unprofitable.

Growing Profit Margin: 290A is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 290A is unprofitable, and losses have increased over the past 5 years at a rate of 41.1% per year.

Accelerating Growth: Unable to compare 290A's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 290A is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (-12%).


Return on Equity

High ROE: 290A has a negative Return on Equity (-68.8%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies